Double maintains 1 strategies that include ADPT - Adaptive Biotechnologies Corp.
Yahoo
Following the approval, ABBV's Emrelis becomes the first FDA-approved therapy for previously treated advanced NSCLC patients with high c-Met protein overexpression.
Yahoo
ALLO's first-quarter earnings match estimates. Devoid of marketed products, the company records nil sales in the quarter.
Yahoo
Does Adaptive Biotechnologies (ADPT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Yahoo
Novavax posts encouraging first-quarter results on the back of an additional $603 million in revenues recognized from the termination of two advanced purchase agreements.
Yahoo
The consensus price target hints at a 26.5% upside potential for Adaptive Biotechnologies (ADPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Yahoo
Here is how Adaptive Biotechnologies (ADPT) and Centene (CNC) have performed compared to their sector so far this year.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TWST | 52.87% | $1.80B | -35.27% | 0.00% |
CRSR | 48.64% | $903.71M | -23.68% | 0.00% |
FLGT | 48.62% | $610.09M | -10.93% | 0.00% |
CPS | 48.57% | $426.42M | +67.01% | 0.00% |
BEAM | 48.43% | $1.73B | -27.49% | 0.00% |
TXG | 48.15% | $1.15B | -64.05% | 0.00% |
BXC | 47.53% | $559.87M | -31.63% | 0.00% |
TECH | 47.44% | $7.56B | -41.77% | 0.49% |
LAW | 47.16% | $252.96M | -40.32% | 0.00% |
CTS | 47.07% | $1.28B | -17.46% | 0.37% |
PHR | 47.03% | $1.51B | +6.90% | 0.00% |
ENVA | 47.01% | $2.47B | +58.92% | 0.00% |
SXI | 46.69% | $1.87B | -10.70% | 0.82% |
COHU | 46.60% | $829.14M | -40.03% | 0.00% |
CERS | 46.48% | $246.60M | -34.18% | 0.00% |
JOBY | 46.30% | $5.67B | +42.63% | 0.00% |
BLFS | 46.09% | $1.05B | +0.09% | 0.00% |
GCO | 45.92% | $267.35M | -10.23% | 0.00% |
NNOX | 45.83% | $347.50M | -44.56% | 0.00% |
LECO | 45.68% | $11.05B | -13.29% | 1.48% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -19.97% | $22.95B | +20.67% | 1.12% |
ED | -18.80% | $36.75B | +5.26% | 3.28% |
DUK | -17.17% | $90.12B | +12.74% | 3.61% |
SO | -15.81% | $96.04B | +10.08% | 3.29% |
CME | -14.98% | $98.74B | +28.80% | 3.84% |
EXC | -13.58% | $43.84B | +12.45% | 3.59% |
AWK | -13.46% | $27.37B | +4.54% | 2.22% |
AEP | -13.13% | $54.28B | +9.80% | 3.61% |
TEF | -12.95% | $27.20B | +8.80% | 6.44% |
T | -12.30% | $196.66B | +57.98% | 4.07% |
OHI | -11.72% | $10.52B | +18.48% | 7.38% |
KR | -10.91% | $44.68B | +24.17% | 1.89% |
BTI | -10.40% | $90.76B | +31.13% | 7.29% |
LITB | -10.36% | $21.28M | -72.45% | 0.00% |
MO | -10.25% | $97.80B | +26.35% | 6.94% |
KMB | -10.21% | $45.57B | +1.99% | 3.58% |
CL | -9.96% | $72.64B | -5.18% | 2.25% |
CABO | -9.88% | $926.89M | -58.34% | 7.13% |
LMT | -9.34% | $108.98B | +0.07% | 2.79% |
MCK | -8.37% | $88.42B | +27.17% | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SUB | -0.05% | $9.40B | 0.07% |
CGSD | 0.06% | $1.19B | 0.25% |
SCHP | -0.11% | $12.81B | 0.03% |
GTIP | -0.18% | $145.27M | 0.12% |
UDN | 0.20% | $137.74M | 0.78% |
IBD | -0.21% | $380.12M | 0.43% |
DFIP | 0.56% | $875.64M | 0.11% |
IBDS | -0.58% | $3.01B | 0.1% |
DFNM | -0.67% | $1.53B | 0.17% |
VUSB | -0.70% | $5.30B | 0.1% |
SGOL | 0.71% | $5.06B | 0.17% |
BAR | 0.76% | $1.10B | 0.1749% |
GLDM | 0.77% | $14.42B | 0.1% |
OUNZ | 0.83% | $1.64B | 0.25% |
AGZD | -0.93% | $127.42M | 0.23% |
IAU | 0.94% | $45.68B | 0.25% |
AAAU | 0.96% | $1.47B | 0.18% |
FXE | 1.00% | $525.40M | 0.4% |
MLN | 1.02% | $532.71M | 0.24% |
TOTL | 1.03% | $3.59B | 0.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -45.82% | $361.41M | 1.43% |
VIXY | -33.34% | $109.64M | 0.85% |
TAIL | -29.58% | $140.49M | 0.59% |
IVOL | -28.55% | $353.94M | 1.02% |
SPTS | -20.90% | $5.76B | 0.03% |
ULST | -20.45% | $637.77M | 0.2% |
XONE | -19.19% | $603.24M | 0.03% |
UTWO | -18.38% | $387.71M | 0.15% |
VGSH | -16.74% | $22.38B | 0.03% |
STPZ | -16.23% | $446.46M | 0.2% |
LDUR | -15.58% | $849.09M | 0.5% |
IBTH | -14.38% | $1.53B | 0.07% |
SCHO | -14.29% | $10.87B | 0.03% |
VTIP | -13.72% | $14.78B | 0.03% |
TPMN | -11.48% | $31.54M | 0.65% |
SHY | -11.22% | $24.03B | 0.15% |
STIP | -11.12% | $11.88B | 0.03% |
IBTI | -11.05% | $995.39M | 0.07% |
IBTJ | -10.70% | $658.04M | 0.07% |
TDTT | -10.56% | $2.47B | 0.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 66.52% | $944.78M | 0.75% |
IWC | 56.32% | $766.88M | 0.6% |
GNOM | 55.71% | $40.65M | 0.5% |
HEAL | 54.90% | $38.16M | 0.5% |
IWO | 53.55% | $11.36B | 0.24% |
GSSC | 52.85% | $538.65M | 0.2% |
IWM | 52.73% | $63.95B | 0.19% |
VTWO | 52.54% | $12.07B | 0.07% |
KOMP | 52.52% | $2.20B | 0.2% |
PSC | 52.30% | $811.78M | 0.38% |
SCHA | 52.22% | $16.91B | 0.04% |
PRFZ | 51.97% | $2.33B | 0.34% |
CPRJ | 51.36% | $48.43M | 0.69% |
NUSC | 50.88% | $1.14B | 0.31% |
KJUL | 50.84% | $113.35M | 0.79% |
IJT | 50.81% | $6.01B | 0.18% |
XBI | 50.80% | $4.85B | 0.35% |
ESML | 50.74% | $1.81B | 0.17% |
IBUY | 50.64% | $153.59M | 0.65% |
EES | 50.60% | $588.44M | 0.38% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AEM | -0.04% | $53.84B | +54.79% | 1.53% |
MDLZ | 0.08% | $84.34B | -9.43% | 2.85% |
PEP | -0.08% | $180.30B | -28.19% | 4.14% |
BULL | 0.09% | $5.67B | +11.22% | 0.00% |
WM | 0.09% | $91.76B | +7.46% | 1.35% |
SBAC | -0.12% | $24.62B | +12.92% | 1.76% |
SAND | 0.12% | $2.39B | +43.23% | 0.72% |
VSTA | 0.23% | $326.82M | +11.64% | 0.00% |
HOLX | 0.23% | $12.42B | -25.63% | 0.00% |
RSG | -0.26% | $76.55B | +30.51% | 0.93% |
CPB | 0.32% | $10.42B | -25.16% | 4.36% |
WTRG | 0.32% | $10.70B | -3.17% | 3.41% |
MSEX | 0.37% | $1.02B | -1.01% | 2.34% |
CARV | -0.38% | $7.41M | -22.87% | 0.00% |
HTO | -0.41% | $1.76B | -13.86% | 3.19% |
PHYS.U | 0.43% | - | - | 0.00% |
WELL | -0.49% | $96.06B | +45.51% | 1.82% |
FTS | 0.50% | $23.72B | +15.88% | 3.70% |
KGC | 0.67% | $16.92B | +75.38% | 0.89% |
FDP | -0.75% | $1.57B | +33.46% | 4.14% |
Current Value
$8.951 Year Return
Current Value
$8.951 Year Return